Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-22

FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for CHATEAL EQ, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitted by Afaxys Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)